Augmented insulin secretory response in early pregnancy.

AIMS/HYPOTHESIS: This study aimed to examine changes in the insulin secretory response in early pregnancy, while accounting for changes in insulin sensitivity. METHODS: This is a secondary analysis of a previously conducted longitudinal physiological study. In 34 women, insulin secretory response (by IVGTT) and insulin sensitivity (by euglycaemic clamp) were assessed prior to pregnancy, in early pregnancy (12-14 weeks gestation) and in late pregnancy (34-36 weeks gestation). Using mixed-effects models, we compared insulin secretory response and sensitivity in early pregnancy to the same variables prior to pregnancy and in late pregnancy, with adjustment for age, obesity status and gestational diabetes mellitus (GDM). We examined changes in insulin secretory response after adjustment for insulin sensitivity using both multivariate modelling and the disposition index (DI). We explored the relationship between insulin secretory response and circulating hormones. RESULTS: The insulin secretory response increased from prior to pregnancy to early pregnancy (unadjusted mean [SD] first-phase insulin response 465.1 [268.5] to 720 [358.2], p < 0.0001) and from early pregnancy to late pregnancy (to 924 [494.6], p = 0.01). Insulin sensitivity increased from prior to pregnancy to early pregnancy (insulin sensitivity index 0.10 [0.04] to 0.12 [0.05], p = 0.001) and decreased in late pregnancy (to 0.06 [0.03], p < 0.0001). Accounting for changes in insulin sensitivity, using either multivariate modelling or the DI, did not attenuate the early-pregnancy augmentation of insulin secretory response. Leptin was positively associated with insulin secretory response, independent of insulin sensitivity and adiposity (p = 0.004). Adjustment for leptin attenuated the observed augmentation of insulin secretory response in early pregnancy (adjusted mean change 121.5, p = 0.13). CONCLUSIONS/INTERPRETATION: The insulin secretory response increases markedly in early pregnancy, prior to and independent of changes in insulin sensitivity. Circulating hormones may mediate this metabolic adaptation. Identifying mediators of this physiological effect could have therapeutic implications for treating hyperglycaemia during and outside of pregnancy.

Birth weight and body composition of neonates born to Caucasian compared with African-American mothers.

OBJECTIVE: To estimate whether neonates of African-American women have lower birth weights because of either decreased lean body mass or fat mass. METHODS: A secondary analysis of a cohort of 104 African-American and 274 Caucasian term, singleton, healthy pregnancies. Women with existing or gestational diabetes were excluded. Neonatal body composition was estimated using anthropometric measurements. RESULTS: There were significant differences in maternal age (29.5 compared with 25.8, P<.001), prepregnancy body mass index (26.2 compared with 30.9 kg/m, P<.001), and weight gain during pregnancy (15.2 compared with 13.4 kg, P=.03) in Caucasian compared with African-American women, respectively. After adjusting for these factors, African-American women's neonates had significantly lower birth weights (3.20 compared with 3.36 kg, P=.003), less lean body mass (2.80 compared with 2.94 kg, P=.002), but no difference in fat mass (392 compared with 417 g, P=.078). CONCLUSION: Decreased birth weight in African-American neonates is due to lower lean body mass and not a difference in adiposity.